HY-P99399-1mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-10mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-P99399-5mg
|
MedChemexpress LLC
|
Semorinemab [CAS 2159141-27-0]
|
|
Neuroscience-Neurodegeneration
|
|
HY-120394-10mg
|
MedChemexpress LLC
|
TVB-3166 [CAS 1533438-83-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-120394-100mg
|
MedChemexpress LLC
|
TVB-3166 [CAS 1533438-83-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-120394-5mg
|
MedChemexpress LLC
|
TVB-3166 [CAS 1533438-83-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-120394-50mg
|
MedChemexpress LLC
|
TVB-3166 [CAS 1533438-83-3]
|
|
Neuroscience-Neurodegeneration
|
|
HY-120394-1mL
|
MedChemexpress LLC
|
TVB-3166 [CAS 1533438-83-3] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
HY-100834-10mg
|
MedChemexpress LLC
|
5,7-Dichlorokynurenic acid [CAS 131123-76-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100834-25mg
|
MedChemexpress LLC
|
5,7-Dichlorokynurenic acid [CAS 131123-76-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100834-5mg
|
MedChemexpress LLC
|
5,7-Dichlorokynurenic acid [CAS 131123-76-7]
|
|
Neuroscience-Neurodegeneration
|
|
HY-100834-50mg
|
MedChemexpress LLC
|
5,7-Dichlorokynurenic acid [CAS 131123-76-7]
|
|
Neuroscience-Neurodegeneration
|
|